Smith & Nephew (LON:SN) has received a consensus recommendation of “Hold” from the twelve research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is GBX 1,340.32 ($19.19).
SN has been the topic of a number of recent analyst reports. JPMorgan Chase raised shares of Smith & Nephew to an “overweight” rating and raised their price target for the company from GBX 1,369 ($19.60) to GBX 1,411 ($20.20) in a research report on Thursday, January 25th. HSBC raised shares of Smith & Nephew to a “buy” rating and raised their price target for the company from GBX 1,320 ($18.90) to GBX 1,530 ($21.91) in a research report on Monday, March 26th. Morgan Stanley dropped their price target on shares of Smith & Nephew from GBX 1,558 ($22.31) to GBX 1,457 ($20.86) and set an “equal weight” rating on the stock in a research report on Tuesday, February 13th. Credit Suisse Group lifted their price objective on shares of Smith & Nephew from GBX 1,285 ($18.40) to GBX 1,290 ($18.47) and gave the stock a “neutral” rating in a research report on Friday, February 9th. Finally, Jefferies Group reaffirmed a “buy” rating on shares of Smith & Nephew in a research report on Thursday, April 12th.
SN opened at GBX 1,352 ($19.36) on Friday. Smith & Nephew has a fifty-two week low of GBX 1,173 ($16.80) and a fifty-two week high of GBX 1,442 ($20.65).
The business also recently disclosed a dividend, which will be paid on Wednesday, May 9th. Shareholders of record on Thursday, April 5th will be given a $0.23 dividend. This is a positive change from Smith & Nephew’s previous dividend of $0.12. The ex-dividend date is Thursday, April 5th. This represents a yield of 1.34%.
In other Smith & Nephew news, insider Graham Baker bought 1,000 shares of Smith & Nephew stock in a transaction dated Tuesday, February 27th. The stock was purchased at an average price of GBX 1,283 ($18.37) per share, for a total transaction of £12,830 ($18,370.56). Also, insider Angie Risley bought 1,601 shares of Smith & Nephew stock in a transaction dated Friday, February 9th. The stock was acquired at an average price of GBX 1,249 ($17.88) per share, with a total value of £19,996.49 ($28,631.86).
TRADEMARK VIOLATION NOTICE: “Smith & Nephew (SN) Given Consensus Rating of “Hold” by Analysts” was originally reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this report on another website, it was copied illegally and republished in violation of international trademark and copyright laws. The legal version of this report can be read at https://www.thelincolnianonline.com/2018/04/22/smith-nephew-sn-given-consensus-rating-of-hold-by-analysts.html.
About Smith & Nephew
Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.